US Archives - Page 131 of 165 - European Medical Journal

Thrombosis Risks Rise in ICI-Treated Lung Cancer

Emerging data highlights a critical complication for patients with metastatic lung cancer undergoing treatment with immune checkpoint inhibitors (ICIs), including PD-1 and PD-L1 blockers.

Vaccine Timing Boosts Cancer Survival Rates

Patients with cancer vaccinated against COVID-19 within 6 months before infection showed significantly higher survival rates, according to a new analysis from the ASCO COVID-19 Registry.

Interview: Roy Fleischmann

There are probably two main reasons. The first is that during medical school and my post-medical school training, the most dynamic…

Remdesivir Lowers 30-Day COVID-19 Readmissions in Vulnerable Patients

A retrospective study highlighted the effectiveness of remdesivir in reducing 30-day COVID-19-related readmissions among vulnerable patient populations, including older adults and those with immunocompromising conditions.

AI, Social Media, and Dermatology: A New Review

A newly published review sheds light on how the digital revolution is reshaping the field of cosmetic dermatology.

AMJ Neurology 1 [Supplement 1]

Explore our latest article summarising key discussions from a symposium at the 40th Congress of the European Committee for…

Ozanimod in Relapsing Multiple Sclerosis: New Insights

Ozanimod is a sphingosine 1-phosphate (S1P) receptor 1 and 5 (S1PR1 and S1PR5) modulator approved in multiple countries for the…

Knee Pain Treatment with Colchicine Falls Short

Investigation into colchicine’s potential as a treatment for knee osteoarthritis (OA) found no significant improvement in pain or function in a recent study.

Eosinophilic Inflammation in Focus: New Trial Data

Benralizumab, a monoclonal antibody targeting eosinophilic inflammation, outperformed prednisolone alone in treating acute exacerbations of asthma and COPD in a new study.

Farming Lessons to Combat Cancer Resistance

Agricultural pest management methods were explored in a new study to determine how they can be adapted to combat cancer treatment resistance.